Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Transplanted hair follicle stem cells can heal damaged rat intestines.

Insulin might be involved in causing hair loss and acne.

Insulin resistance is a complex condition that can lead to many diseases and has few treatment options.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

The hydrogel with a 1:3 ratio of hydroxyethyl cellulose to hyaluronic acid is effective for delivering drugs through the skin to treat acne.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.